ImmuCell Corp (ICCC)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description-A detailed description of the company's operations and business divisions.
- Corporate strategy-Analyst's summarization of the company's business strategy.
- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.
- Company history-Progression of key events associated with the company.
- Major products and services-A list of major products, services and brands of the company.
- Key competitors-A list of key competitors to the company.
- Key employees-A list of the key executives of the company.
- Executive biographies-A brief summary of the executives' employment history.
- Key operational heads-A list of personnel heading key departments/functions.
- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities-A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
ImmuCell Corp (Immucell) is an animal health biotechnology company. It develops, manufactures and markets products that improve animal health and productivity in the dairy and beef industries. The company focuses on the prevention, diagnosis and treatment of bovine diseases. The company's major products include First Defense bovine coronavirus-escherichia coli antibody and Wipe Out dairy wipes. Immucell is also developing Mast Out, an intramammary infusion product for the treatment of subclinical mastitis in lactating dairy cows. The company develops its products based on the requirement in two areas, namely, Intelligent Mastitis Management and Calf Health. The company sells its products through distributors and dairy producers. ImmuCell is headquartered in Portland, Maine, the US.
ImmuCell Corp Key Recent Developments
May 14,2018: ImmuCell Announces Financial Results for First Quarter of 2018
Feb 08,2018: ImmuCell Announces Preliminary Financial Results for Fourth Quarter and Full Year 2017
Jan 30,2018: ImmuCell Appoints Two New Members to its Board of Directors
Aug 14,2017: ImmuCell Announces Financial Results for Second Quarter of 2017
Mar 08,2017: Bobbi Jo Brockmann is appointed to Board of Directors of ImmuCell
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1-About the Company 5
ImmuCell Corp-Key Facts 5
ImmuCell Corp-Key Employees 6
ImmuCell Corp-Key Employee Biographies 7
ImmuCell Corp-Major Products and Services 8
ImmuCell Corp-History 9
ImmuCell Corp-Locations And Subsidiaries 10
Head Office 10
Section 2-Company Analysis 11
Company Overview 11
ImmuCell Corp-Business Description 12
ImmuCell Corp-SWOT Analysis 13
SWOT Analysis-Overview 13
ImmuCell Corp-Strengths 13
ImmuCell Corp-Weaknesses 14
ImmuCell Corp-Opportunities 15
ImmuCell Corp-Threats 16
ImmuCell Corp-Key Competitors 17
Section 3-Company Financial Ratios 18
Financial Ratios-Capital Market Ratios 18
Financial Ratios-Annual Ratios 19
Performance Chart 22
Financial Performance 22
Financial Ratios-Interim Ratios 23
Financial Ratios-Ratio Charts 24
Section 4-Company's Recent Developments 25
May 14, 2018: ImmuCell Announces Financial Results for First Quarter of 2018 25
Feb 08, 2018: ImmuCell Announces Preliminary Financial Results for Fourth Quarter and Full Year 2017 27
Section 5-Appendix 29
Ratio Definitions 29
About GlobalData 33
Contact Us 33
List of Figures
ImmuCell Corp, Performance Chart (2013-2017) 22
ImmuCell Corp, Ratio Charts 24
List of Tables
ImmuCell Corp, Key Facts 5
ImmuCell Corp, Key Employees 6
ImmuCell Corp, Key Employee Biographies 7
ImmuCell Corp, Major Products and Services 8
ImmuCell Corp, History 9
ImmuCell Corp, Key Competitors 17
ImmuCell Corp, Ratios based on current share price 18
ImmuCell Corp, Annual Ratios 19
ImmuCell Corp, Annual Ratios (Cont...1) 20
ImmuCell Corp, Annual Ratios (Cont...2) 21
ImmuCell Corp, Interim Ratios 23
Currency Codes 29
Capital Market Ratios 29
Equity Ratios 30
Profitability Ratios 30
Cost Ratios 31
Liquidity Ratios 31
Leverage Ratios 32
Efficiency Ratios 32
Single User License:
Corporate User License:
Idexx Laboratories Inc
Elanco Animal Health Inc
Merck Animal Health
Boehringer Ingelheim Animal Health Gmbh
ImmuCell Corp, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts
select a license
NEWSLETTER BY CATEGORY
The report was very informative and gives me an interesting view on the Indian market.... "Area Sales Manager, Muhlen Sohn GmbH & Co. KG"
We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help... "Group Vice President Strategy, Aliaxis"
I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again... "Technical Marketing Manager, Ascendis Health Limited"
I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ... "., Coldwell Banker - Riyadh "
The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future... "International and Business Dev. Director, Duta Abadi Primantara"